PrEP may be giving some homosexual and heterosexual users a false sense of security.
South Africa's data rollout of its pre-exposure prophylaxis shows that there is a relatively slow, but increasing, uptake. However, more needs to be done to target young women.
Stigma stops people from getting tested for HIV, and staying on their treatment. Unless it's addressed, the AIDS epidemic will persist.
Trials have shown that rates of HIV infection are reduced if people not infected with HIV take anti-retrovirals - known as pre-exposure prophylaxis (PrEP). But adherence to a daily dose is a problem.
Ignoring those at 'high risk' of HIV in order to sustain the idea of the 'good' gay man will only perpetuate the virus.
A judge has found that NHS England cannot reasonably refuse to fund anti-HIV drugs for gay men. This is a major step forward.
The focus of the 2016 International AIDS Conference has on access to necessary antiretrovirals, equity and making sure no-one is left behind. But there is a funding gap that needs to be addressed.
Thanks to treatment advances, people with HIV can and do live long and full lives. And that has led to a challenge that doctors and patients may not have imagined 35 years ago: the aging HIV patient.
Just how much disclosure is it reasonable to expect from a sex partner, particularly if that relationship isn't a serious and committed one?
Used properly and consistently, condoms are the most effective, affordable, and low-tech way to prevent HIV. But unfortunately, condoms are not an easy option for everyone – particularly women.
Charlie Sheen’s recent announcement that he has HIV has raised concerns about whether he may have transmitted the infection to other people.
A pill a day can prevent HIV, but there's no guarantee Australians will get access to this intervention anytime soon.
Despite health promotion campaigns and a concerted effort to make antiretroviral therapy more accessible, the number of new HIV cases in Australia has remained stable over the last three years.